吸烟、遗传易感性与早绝经:揭示生物学机制与潜在治疗靶点
基于英国生物银行139869名女性的观察性及转录组关联分析,探讨吸烟与遗传易感性对早绝经的影响。吸烟超过30包年的女性早绝经风险约升高1.5倍,不同遗传风险组RR为1.39至1.45。转录组关联分析识别出IMMP2L、BMPR2、HMGN1等核心基因,孟德尔随机化证实每日吸烟量是早绝经的因果因素,并预测出SP600125、INCB18424和鲁索替尼等潜在治疗靶点。
要点
- 吸烟超过30包年女性早绝经风险约升高1.5倍,低、中、高遗传风险组RR分别为1.39、1.45、1.45。
- 转录组关联分析识别出IMMP2L、BMPR2和HMGN1等核心基因。
- 孟德尔随机化证实每日吸烟量是早绝经的因果因素,并预测出SP600125、INCB18424和鲁索替尼等潜在治疗靶点。
核心结论
- 减少吸烟可显著降低早绝经风险,识别的核心基因和治疗靶点为减轻吸烟有害效应提供了新途径。
研究设计与样本
- 观察性及转录组关联分析(TWAS)研究,数据来自英国生物银行和公开汇总统计。
- 纳入139869名具有完整基线和绝经数据且无妇科手术史的女性。
- 采用调整的修正泊松回归模型确定吸烟和遗传风险对早绝经的影响,TWAS识别吸烟与早绝经间的基因表达,孟德尔随机化推断因果性。
主要发现
- 吸烟超过30包年的女性早绝经风险约升高1.5倍,低、中、高遗传风险组RR分别为1.39(95%CI 1.23-1.56)、1.45(95%CI 1.33-1.59)和1.45(95%CI 1.36-1.55)。
- TWAS识别出IMMP2L、BMPR2和HMGN1等核心基因。
- 孟德尔随机化证实每日吸烟量是早绝经的因果因素。
- 识别出SP600125、INCB18424和鲁索替尼等潜在治疗靶点。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To explore the association between smoking, genetic susceptibility and early menopause (EM) and clarify the potential mechanisms underlying this relationship. DESIGN: An observational and Transcriptome-wide association analysis (TWAS) study. SETTING: UK Biobank and public summary statistics. POPULATION: 139 869 women with full baseline and menopause data, and no gynaecological surgery history. METHODS: Adjusted modified Poisson regression models were developed to determine the smoking and genetic risk effects on EM. TWAS was used to identify gene expression between smoking and EM, with Mendelian randomisation (MR) to infer causality. Enrichment analysis explored regulatory networks of transcription factors, microRNAs and potential therapeutic targets. Small molecule drugs were predicted using drug-gene interaction analysis. MAIN OUTCOME MEASURES: EM prevalence and common gene expression patterns. RESULTS: Women with over 30 pack-years of smoking had about 1.5 times higher EM risk, with RRs of 1.39 (95%CI, 1.23-1.56), 1.45 (1.33-1.59) and 1.45 (1.36-1.55) in the low, intermediate and high genetic risk groups. TWAS identified hub genes such as IMMP2L, BMPR2 and HMGN1. MR confirmed daily cigarette consumption as a causal factor in early menopause. Several potential therapeutic targets (e.g., SP600125, INCB18424 and ruxolitinib) were identified. CONCLUSIONS: Smoking reduction significantly lowered the risk of EM. Hub genes and therapeutic targets identified provided new avenues for mitigating harmful effects of smoking.
引用
- Liang Y, Ou J, Fu J, et al. Smoking, Genetic Susceptibility and Early Menopause: Unveiling Biological Mechanisms and Potential Therapy Targets. BJOG. 2024. PMID: 39727065. doi:10.1111/1471-0528.18052
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。